Boston Scientific Corp. vs. ResMed Inc.
Boston Scientific Corp. (BSX) comes out ahead, leading on 7 of 9 compared factors.
Size & Scale
| BSX | RMD | |
|---|---|---|
| Market Cap | $63.11 billion | $32.93 billion |
| Revenue (TTM) | $21.00 billion | $5.65 billion |
| Net Income (TTM) | $3.67 billion | $1.52 billion |
BSX leads on 3 of 3 size & scale factors.
Valuation
| BSX | RMD | |
|---|---|---|
| P/E Ratio | 17.55 | 21.90 |
| Price / Book | 2.51 | 5.00 |
| Price / Sales | 3.01 | 5.82 |
BSX leads on 3 of 3 valuation factors.
Profitability
| BSX | RMD | |
|---|---|---|
| Net Margin | 17.47% | 26.94% |
| Return on Equity | 14.58% | 23.13% |
RMD leads on 2 of 2 profitability factors.
Dividend
| BSX | RMD | |
|---|---|---|
| Dividend Yield | — | 1.16% |
| Payout Ratio | — | 25.31 |
BSX and RMD split the dividend factors evenly.
Risk & Sentiment
| BSX | RMD | |
|---|---|---|
| Short Interest | 0.72% | 4.04% |
BSX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.